A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
about
Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption.Bovine immunoglobulin/protein isolate binds pro-inflammatory bacterial compounds and prevents immune activation in an intestinal co-culture model.Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.Structure-Function Analysis of Phenylpiperazine Derivatives as Intestinal Permeation Enhancers.Excipient foods: designing food matrices that improve the oral bioavailability of pharmaceuticals and nutraceuticals.Oral bioavailability: issues and solutions via nanoformulations.Enhanced and Extended Anti-Hypertensive Effect of VP5 Nanoparticles.Excipient Nanoemulsions for Improving Oral Bioavailability of Bioactives.Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).Intestinal micropatches for oral insulin delivery.Delivery of Exenatide and Insulin Using Mucoadhesive Intestinal Devices.Oral delivery of biologics using drug-device combinations.TRPA1-dependent reversible opening of tight junction by natural compounds with an α,β-unsaturated moiety and capsaicin.Enhancement of oral insulin bioavailability: in vitro and in vivo assessment of nanoporous stimuli-responsive hydrogel microparticles.Evaluation of γ-cyclodextrin effect on permeation of lipophilic drugs: application of cellophane/fused octanol membrane.Intestinal mucoadhesive devices for oral delivery of insulin.
P2860
Q35147276-F82F09E7-6938-4A79-9C8D-ECBA66826932Q35592017-C2A2C98B-D178-440F-B2DD-401A629955CFQ35684362-6236C484-306D-44F6-83AF-AF3AA12EA82CQ36333460-CBC92328-1898-4773-8F85-860344F2A36FQ38206716-606BCDF2-7A20-4C58-BFAB-EBC3CD568A65Q38349734-F9B31D1B-0345-4821-B8AE-30ACA5752639Q38789463-179F5190-F59D-4768-A4C1-B2218E7C74BEQ39201371-BC0DDEFA-C1C0-4BF0-B9B0-6BD0D31C0BB5Q40728949-2DE3AFB4-9465-410E-A851-96AC1228EA04Q42045663-32F67A91-0778-4D7C-8AA7-6D82FEFB7C5CQ46929341-C050C507-D267-4E40-B512-BF3205DC5141Q47830247-79756545-46C6-4835-A71F-D2D21C51D572Q49357566-238F7B62-184A-4FA3-B2B6-2EC8929F3598Q53156796-CFECFC23-9F74-421E-8D3D-9001FFEEAD5CQ54440180-C1C97A47-C805-46D0-977C-198592FD2920Q55023208-8D1049F6-C930-4F15-BD14-0ED0DD7D7394
P2860
A permeation enhancer for increasing transport of therapeutic macromolecules across the intestine.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A permeation enhancer for incr ...... olecules across the intestine.
@en
A permeation enhancer for incr ...... olecules across the intestine.
@nl
type
label
A permeation enhancer for incr ...... olecules across the intestine.
@en
A permeation enhancer for incr ...... olecules across the intestine.
@nl
prefLabel
A permeation enhancer for incr ...... olecules across the intestine.
@en
A permeation enhancer for incr ...... olecules across the intestine.
@nl
P50
P1476
A permeation enhancer for incr ...... molecules across the intestine
@en
P2093
Nishit Doshi
Samir Mitragotri
P304
P356
10.1016/J.JCONREL.2013.05.002
P407
P577
2013-05-14T00:00:00Z